Literature DB >> 19858736

Rapid aldosterone signaling and vascular reactivity: relax or don't do it.

Jane A Leopold1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19858736      PMCID: PMC2797578          DOI: 10.1097/FJC.0b013e3181c37ddc

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  30 in total

Review 1.  Aldosterone.

Authors:  Rachell E Booth; John P Johnson; James D Stockand
Journal:  Adv Physiol Educ       Date:  2002-12       Impact factor: 2.288

Review 2.  Impact of aldosterone on vascular pathophysiology.

Authors:  Allan D Struthers
Journal:  Congest Heart Fail       Date:  2002 Jan-Feb

3.  Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure.

Authors:  C A Farquharson; A D Struthers
Journal:  Circulation       Date:  2000-02-15       Impact factor: 29.690

4.  Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Authors:  Bertram Pitt; Willem Remme; Faiez Zannad; James Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay Kleiman; Marjorie Gatlin
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.

Authors:  Colin A J Farquharson; Allan D Struthers
Journal:  Clin Sci (Lond)       Date:  2002-10       Impact factor: 6.124

6.  Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Authors:  Bradley A Maron; Ying-Yi Zhang; Diane E Handy; Annie Beuve; Shiow-Shih Tang; Joseph Loscalzo; Jane A Leopold
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

7.  Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.

Authors:  Erwan Heylen; An Huang; Dong Sun; Gabor Kaley
Journal:  J Cardiovasc Pharmacol       Date:  2009-12       Impact factor: 3.105

8.  Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.

Authors:  Nermin Kuzkaya; Norbert Weissmann; David G Harrison; Sergey Dikalov
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

9.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

Authors:  Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

10.  Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endothelium.

Authors:  Anar Dossumbekova; Evgeny V Berdyshev; Irina Gorshkova; Zuohui Shao; Changqing Li; Phillip Long; Atul Joshi; Viswanathan Natarajan; Terry L Vanden Hoek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

View more
  4 in total

Review 1.  Mineralocorticoid receptors in vascular function and disease.

Authors:  Amy McCurley; Iris Z Jaffe
Journal:  Mol Cell Endocrinol       Date:  2011-06-24       Impact factor: 4.102

Review 2.  Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.

Authors:  Kathleen V Barrett; Amy T McCurley; Iris Z Jaffe
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

Review 3.  Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.

Authors:  Amy McCurley; Adam McGraw; Dafina Pruthi; Iris Z Jaffe
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

4.  Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.

Authors:  Nathanne S Ferreira; Stêfany B A Cau; Marcondes A B Silva; Carla P Manzato; Fabíola L A C Mestriner; Takayuki Matsumoto; Fernando S Carneiro; Rita C Tostes
Journal:  Front Pharmacol       Date:  2015-03-02       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.